The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124179243 12417924 3 F 20151203 20160728 20160531 20160805 EXP JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-024286 BRISTOL MYERS SQUIBB 72.76 YR M Y 59.00000 KG 20160805 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124179243 12417924 1 PS SPRYCEL DASATINIB 1 Oral 100 MG, QD Y 21986 100 MG FILM-COATED TABLET QD
124179243 12417924 2 SS SPRYCEL DASATINIB 1 Oral 50 MG, QD Y 21986 50 MG FILM-COATED TABLET QD
124179243 12417924 3 SS SPRYCEL DASATINIB 1 Oral 100 MG, QD Y 21986 100 MG FILM-COATED TABLET QD
124179243 12417924 4 SS SPRYCEL DASATINIB 1 Oral 50 MG, QD Y 21986 50 MG FILM-COATED TABLET QD
124179243 12417924 5 C CASODEX BICALUTAMIDE 1 Oral 80 MG, QD U 0 80 MG TABLET QD
124179243 12417924 6 C DENOTAS CALCIUM CARBONATECHOLECALCIFEROLMAGNESIUM CARBONATE 1 Oral 1 TAB, BID U 0 1 DF TABLET BID
124179243 12417924 7 C MEVALOTIN PRAVASTATIN SODIUM 1 Oral 10 MG, QD U 0 10 MG TABLET QD
124179243 12417924 8 C NIFEDIPINE. NIFEDIPINE 1 Oral 10 MG, QD U 0 10 MG TABLET QD
124179243 12417924 9 C VALSARTAN. VALSARTAN 1 Oral 80 MG, QD U 0 80 MG TABLET QD
124179243 12417924 10 C LEUPLIN LEUPROLIDE ACETATE 1 Subcutaneous 11.25 MG, QMO U 0 11.25 MG /month
124179243 12417924 11 C RANMARK DENOSUMAB 1 Subcutaneous 120 MG, UNK U 0 120 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124179243 12417924 1 Chronic myeloid leukaemia
124179243 12417924 5 Prostate cancer
124179243 12417924 6 Prostate cancer
124179243 12417924 7 Product used for unknown indication
124179243 12417924 8 Product used for unknown indication
124179243 12417924 9 Product used for unknown indication
124179243 12417924 10 Prostate cancer
124179243 12417924 11 Prostate cancer

Outcome of event

Event ID CASEID OUTC COD
124179243 12417924 HO
124179243 12417924 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124179243 12417924 Anaemia
124179243 12417924 Cystitis
124179243 12417924 Cystitis haemorrhagic
124179243 12417924 Eyelid oedema
124179243 12417924 Haematuria
124179243 12417924 Haemorrhoids
124179243 12417924 Lower gastrointestinal haemorrhage
124179243 12417924 Melaena
124179243 12417924 Oedema peripheral
124179243 12417924 Packed red blood cell transfusion
124179243 12417924 Pleural effusion
124179243 12417924 Procoagulant therapy
124179243 12417924 Proctitis haemorrhagic
124179243 12417924 Rash
124179243 12417924 Urinary retention

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124179243 12417924 1 20151201 0
124179243 12417924 3 20151130 20160330 0
124179243 12417924 4 20160420 0
124179243 12417924 7 20151127 0
124179243 12417924 11 201510 20160419 0